Inflammasome-targeting natural compounds in inflammatory bowel disease: Mechanisms and therapeutic potential.

Xu, Qiuyun; Sun, Weichen; Zhang, Jie; Mei, Youmin; Bao, Jingyin; Hou, Shengping; Zhou, Xiaorong; Mao, Liming

Xu, Qiuyun; Sun, Weichen; Zhang, Jie; Mei, Youmin; Bao, Jingyin; Hou, Shengping; Zhou, Xiaorong; Mao, Liming.

Afiliación

Xu Q; Department of Immunology, School of Medicine, Nantong University, Nantong, China.
Sun W; Department of Immunology, School of Medicine, Nantong University, Nantong, China.
Zhang J; Department of Immunology, School of Medicine, Nantong University, Nantong, China.
Mei Y; Department of Periodontology, Nantong Stomatological Hospital, Nantong, China.
Bao J; Basic Medical Research Center, School of Medicine, Nantong University, Nantong, China.
Hou S; The First Affiliated Hospital of Chongqing Medical University, Chongqing Eye Institute, Chongqing Key Laboratory of Ophthalmology, Chongqing, China.
Zhou X; Department of Immunology, School of Medicine, Nantong University, Nantong, China.
Mao L; Department of Immunology, School of Medicine, Nantong University, Nantong, China.

Front Immunol ; 13: 963291, 2022.

Article en En | MEDLINE | ID: mdl-36090968

Asunto(s)

Colitis Ulcerosa; Colitis; Enfermedad de Crohn; Enfermedades Inflamatorias del Intestino; Animales; Enfermedad Crónica; Humanos; Inflamasomas; Proteína con Dominio Pirina 3 de la Familia NLR

Palabras clave

IL-1ß; NLRP3; inflammasome; inflammatory bowel disease; natural compounds; traditional medicine

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedades Inflamatorias del Intestino / Colitis Ulcerosa / Enfermedad de Crohn / Colitis Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Front Immunol Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google